CDTX vs ROST · rev $1.3M vs P/E 21, rev $21.13B
Cidara Therapeutics Inc (CDTX) versus Ross Stores Inc (ROST) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Ross Stores Inc (ROST) is a apparel retail company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported ROST revenue for 2025-02-01 was $21.13B. Net income was $2.09B. Revenue was up 3.7% from 2024-02-03 to 2025-02-01. ROST currently screens at market cap $43.03B and trailing P/E 20.8.
CDTX currently screens at market cap $6.96B. ROST currently screens at market cap $43.03B and trailing P/E 20.8.
Not investment advice. Open the CDTX and ROST stock pages for the full models.
Not investment advice.